Bio Pharma Dive

JANUARY 28, 2021

Significant setbacks for pace-setting programs from BioMarin and UniQure have renewed questions about gene therapy’s promise, and its safety.

Gene Therapy 358

Gene Therapy Gene 358

World of DTC Marketing

JANUARY 27, 2021

SUMMARY: Pharma has not embraced a content strategy when the number of online health seekers is climbing. A content management strategy can lead to a better brand-patient relationship and turn customers into brand ambassadors. I’m not a huge believer in content strategy for CPGs. I feel that there is so much content already out there that people don’t have the time to read it all.

Branding 202

Branding Production Marketing 202

Pharma Times

JANUARY 28, 2021

Study suggests that palbociclib could be used to treat around a fifth of people with TNBC

Research 156

Research 156

BioSpace

JANUARY 25, 2021

An in vitro study conducted by scientists from Northwestern University and Utah State University concluded that components found within the Xlear nasal spray, particularly grapefruit seed extract and xylitol, were successful in statistically reducing the amount of SARS-CoV-2 in a patient.

In-Vitro 145

In-Vitro Scientist 145

Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

Clinical Trials

Bio Pharma Dive

JANUARY 28, 2021

So far, both Pfizer's and Moderna's vaccines appear to work against more transmissible variants, but preparation is underway for the day they don't.

Vaccination 356

Vaccination Vaccine 356

World of DTC Marketing

JANUARY 25, 2021

SUMMARY: The LinkedIn team had a unique take on measuring ROI. “77% of marketers measure ROI within the first month of their campaign, knowingly trying to “prove ROI in a shorter amount of time than their typical sales cycle., while only 4% of marketers even measure ROI over a six-month period or longer.” So how should DTC marketers really measure ROI?

Marketing 187

Marketing Branding Sales Production 187

pharmaphorum

JANUARY 29, 2021

Genome editing is an exciting but still nascent field, and companies in the area face as many obstacles as they do opportunities. Sangamo CEO Sandy Macrae told us how his company is being cautious about the hype and finding ways to be financially viable in an emerging space. ‘Cutting edge’ is, for once, a truly apt description when it comes to gene editing – both because the field is pushing medicine into areas we might never have dreamed possible, and because these technologies involve literall

Gene Editing 145

Gene Editing Gene Gene Therapy In-Vivo 145

Bio Pharma Dive

JANUARY 26, 2021

The French drugmaker, having hit delays with its own coronavirus shot, agreed to manufacture over 100 million doses of Pfizer and BioNTech's vaccine for supply in Europe.

Vaccination 355

Vaccination Vaccine Manufacturing 355

World of DTC Marketing

JANUARY 26, 2021

SUMMARY: Digital is a way of thinking; it’s not a tactic. To many going digital can mean a ton of opportunities but if you move too quickly you can lose sight of the end goal. Is your organization digital ready? It’s a question that I ask all of my clients at a time when more people are going online for health information. But let’s start at the beginning… 1ne: What’s the purpose of your product website?

Branding 180

Branding Production Marketing Pharma Companies 180

Pharma Times

JANUARY 26, 2021

Lab tests evaluated vaccine's efficacy against UK and South African variants

Vaccine 142

Vaccine Vaccination 142

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Medicine

pharmaphorum

JANUARY 27, 2021

As the largest single-payer healthcare system in Europe, the UK’s National Health Service (NHS) has a uniquely beneficial health data and real-world evidence (RWE) environment. It’s one that has global potential to improve patient outcomes but efforts to harness the true potential of these information flows are only just beginning. The foundation for this is the NHS’ longstanding commitment to collecting healthcare data.

Clinical Trials 143

Clinical Trials Clinical Trials Research Trials 143

Bio Pharma Dive

JANUARY 29, 2021

The vaccine's efficacy was higher in the U.S., but lower in Latin America and South Africa, where new, more infectious virus variants are circulating.

Vaccination 354

Vaccination Vaccine Trials 354

World of DTC Marketing

JANUARY 29, 2021

SUMMARY: The future of healthcare involves digital transformation but moving too fast in a matrix management environment can cause problems and set digital back months. Most of us know the importance of digital when to comes to healthcare. The pandemic has accelerated digital transformation, but organizations need to be careful about moving too fast without getting company influencers’ buy-in.

Marketing 154

Marketing Research 154

Camargo

JANUARY 27, 2021

Comparing Orphan Drug, Rare Pediatric Disease, and Humanitarian Use Device Designations. The US FDA offers sponsors a variety of special designation programs to incentivize them to develop and deliver therapies to treat unmet patient needs, such as Fast Track Designation (FTD), Breakthrough Therapy Designation , and Qualified Infectious Disease Product Designation.

Production 138

Production Drugs Marketing Regulation 138

Advertisement

Clinical Supply

pharmaphorum

JANUARY 26, 2021

From telehealth to digital trials, customer engagement to healthcare data, Healthware Group outlines the key trends that are expected to shake up digital health this year. Well, it goes without saying, COVID-19 has resulted in a rapid adoption of digital technologies across all industries, most notably in healthcare. There are several important aspects to these shifts for pharma, biotech and medical device companies, so what can we expect to see over the next 12 months and beyond?

Clinical Trials 141

Clinical Trials Clinical Trials Sales Life Science 141

Bio Pharma Dive

JANUARY 25, 2021

The drugmaker, one of the largest vaccine developers globally, won't move forward with either of two candidates it's been testing after disappointing data in early trials.

Vaccination 351

Vaccination Vaccine Development Trials 351

Pharma Times

JANUARY 27, 2021

Cost-effectiveness agency initially turned down the drug in this setting

Drugs 137

Drugs 137

Pharma Mirror

JANUARY 26, 2021

Navigating your way to a career in the medical field is not easy. You may have spent late nights studying for exams and long hours working in a medical institute. But, you are finally here about to get your nursing license in the state of Georgia. When applying for a nursing license or getting your old one renewed, you might face some trouble if the background check doesn’t show up clean.

Nurses 130

Nurses Licensing Licensing 130

Advertisement

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

Clinical Trials

pharmaphorum

JANUARY 29, 2021

JAK inhibitor Xeljanz is one of Pfizer’s top-selling drugs, despite a ‘black box’ warning for blood clots and cancers added to its label in 2019. Now, a study designed to prove its safety has achieved the opposite. The post-marketing safety study showed that Xeljanz (tofacitinib) – used to treat rheumatoid arthritis (RA) – was associated with a higher rate of heart attacks and cancer than a TNF inhibitor in patients aged over 50 with underlying cardiovascular risk factors.

Trials 135

Trials Marketing Drugs Sales 135

Bio Pharma Dive

JANUARY 27, 2021

A large safety study found that patients given Pfizer's Xeljanz had health issues like major heart complications and cancer at a higher rate than those who got a different kind of anti-inflammation drug.

Drugs 345

Drugs 345

Pharma Times

JANUARY 28, 2021

The New Variant Assessment Platform will be led by Public Health England

Genomics 130

Genomics Genome 130

BioSpace

JANUARY 25, 2021

Gene therapies offer great reward in the form of treating various devastating diseases, but there are also significant risks.

Gene Therapy 129

Gene Therapy Gene Medicine 129

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Clinical Trials

pharmaphorum

JANUARY 29, 2021

The future of life sciences CRM will be defined by rapid digital transformation and a focus on customer experience – and those who stick to old ways of working will be left in the dust, according to new research from Gartner. Gartner’s’ CRM market guide notes that AI, digital scalability and hyper-automation hold the keys to sales success in the post-COVID era, and they highlight the providers who are using digital transformation to find new ways of engaging customers.

Life Science 126

Life Science Sales Marketing Pharma Companies 126

Bio Pharma Dive

JANUARY 26, 2021

The results show that drugs from both companies can help prevent or treat COVID-19 when given at the right time. But that won't mean much if barriers to use remain high.

Antibody 338

Antibody Drugs 338

BioPharma Reporter

JANUARY 25, 2021

The European Ombudsman is investigating the secrecy with which the EU executive is handling COVID-19 vaccine supply contracts.

Vaccine 127

Vaccine Vaccination Regulation Marketing 127

Pharma Times

JANUARY 25, 2021

BTK inhibitor demonstrated non-inferior progression-free survival compared to Imbruvica

125

125

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

Clinical Research

pharmaphorum

JANUARY 25, 2021

The clinical research community has been disrupted in a number of ways due to COVID-19 and sparked a spirit of collaboration and innovation. Worldwide Clinical Trial’s Aman Khera gives five predictions of how clinical research could change in 2021. The pandemic has propelled the life science industry toward higher expectations for faster, more responsive and more inclusive drug development.

Clinical Research 124

Clinical Research Research Clinical Trials Clinical Trials 124

Bio Pharma Dive

JANUARY 28, 2021

A small upfront payment gives Merck access to a program from Artiva Biotherapeutics that aims to create "off-the-shelf" CAR-NK cell therapies for solid tumors.

336

336

NY Times

JANUARY 26, 2021

President Biden said the amount of coronavirus vaccines reaching the states would rise next week and a deal was near to provide enough shots to vaccinate nearly all Americans by the end of summer.

Vaccine 124

Vaccine Vaccination Drugs 124

Pharma Times

JANUARY 29, 2021

Datopotamab deruxtecan and Enhertu were evaluated in non-small cell lung cancer patients

Antibody 123

Antibody Trials Drugs 123

Advertisement

Clinical Supply